Press Releases

Date	Title	Company
13-Nov-2023	Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics	Businesswire
13-Nov-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of E2open Parent Holdings, Inc. (ETWO) on Behalf of Investors	Businesswire
13-Nov-2023	Q2 Announces New Executive Appointments	Businesswire
13-Nov-2023	MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)	Businesswire
13-Nov-2023	MedinCell salue la collaboration entre Teva et Royalty Pharma visant à accélérer le développement du programme olanzapine LAI (nom de code : mdc-TJK ou TEV-‘749)	Businesswire
13-Nov-2023	$15.2+ Bn T-Cell therapy Market to Grow at 18.3% CAGR, Globally, by 2032	The Wire Times
13-Nov-2023	Bloomsbury Genetic Therapies Celebrates its One Year Anniversary and Outlines Key Strategic and Operational Achievements since Launch	Bloomsbury Genetic Therapies
13-Nov-2023	OGT to premiere SureSeq™ Myeloid MRD panel at AMP	OGT, A Sysmex Group Company
13-Nov-2023	IO Biotech Announces 2023 Third Quarter Results	IO Biotech
13-Nov-2023	IO Biotech Appoints Helen Collins, MD, to its Board of Directors	IO Biotech
13-Nov-2023	Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD	Resolution Therapeutics Limited
13-Nov-2023	Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease	Mission Therapeutics
13-Nov-2023	KFSH&RC Succeeds in Applying Advanced Gene Therapy for Patients with Hemophilia	KFSH&RC
13-Nov-2023	Oxolife Appoints International Fertility Experts to its Scientific Advisory Board	Oxolife
13-Nov-2023	Model N Management to Present at the RBC Capital Markets Global Technology, Internet, Media, Telecommunications Conference	Businesswire
13-Nov-2023	Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology	Businesswire
13-Nov-2023	Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology	Businesswire
13-Nov-2023	Kelso Pharma initiates European expansion with acquisition of Italian specialty pharma company, Velit Biopharma	Kelso Pharma
13-Nov-2023	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3	Businesswire
13-Nov-2023	Thermo Fisher Scientific Opens Customer Experience Center for Battery Manufacturing in Seoul	Businesswire